falseQ10001856242--12-31DC 0001856242 2022-01-01 2022-03-31 0001856242 2021-03-30 2021-03-31 0001856242 2022-03-31 0001856242 2021-12-31 0001856242 2022-01-11 0001856242 2022-01-11 2022-01-11 0001856242 2021-03-29 0001856242 2021-03-31 0001856242 us-gaap:CapitalUnitsMember 2022-01-01 2022-03-31 0001856242 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001856242 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001856242 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001856242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001856242 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001856242 cxac:RestrictionOnTransferOfSponsorSharesMember us-gaap:CommonClassAMember cxac:SponsorMember 2022-01-01 2022-03-31 0001856242 cxac:SponsorMember cxac:AdministrationAndSupportServicesMember 2022-01-01 2022-03-31 0001856242 srt:ChiefFinancialOfficerMember cxac:AdministrationAndSupportServicesMember 2022-01-01 2022-03-31 0001856242 us-gaap:IPOMember 2022-01-01 2022-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember cxac:PublicWarrantsMember 2022-01-01 2022-03-31 0001856242 cxac:PublicWarrantsMember 2022-01-01 2022-03-31 0001856242 cxac:PrivateWarrantsMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001856242 cxac:PrivateWarrantsMember 2022-01-01 2022-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001856242 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001856242 cxac:SponsorMember cxac:PrivatePlacementWarrantMember 2022-01-01 2022-03-31 0001856242 cxac:PrivatePlacementWarrantMember 2022-01-01 2022-03-31 0001856242 us-gaap:PrivatePlacementMember cxac:PrivatePlacementWarrantMember 2022-01-01 2022-03-31 0001856242 cxac:FromTheCompletionOfBusinessCombinationMember cxac:PublicWarrantsMember 2022-01-01 2022-03-31 0001856242 cxac:FromTheCompletionOfBusinessCombinationMember cxac:PublicWarrantsMember us-gaap:IPOMember 2022-01-01 2022-03-31 0001856242 cxac:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001856242 cxac:UnderwritingAgreementMember 2022-01-01 2022-03-31 0001856242 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-03-31 0001856242 us-gaap:RetainedEarningsMember 2021-03-30 2021-03-31 0001856242 us-gaap:CommonClassBMember 2022-03-31 0001856242 us-gaap:CommonClassAMember 2022-03-31 0001856242 cxac:SponsorMember us-gaap:CommonClassAMember cxac:RestrictionOnTransferOfSponsorSharesMember 2022-03-31 0001856242 cxac:WorkingCapitalLoansMember 2022-03-31 0001856242 cxac:PromissoryNoteMember cxac:SponsorMember 2022-03-31 0001856242 us-gaap:AccountsPayableAndAccruedLiabilitiesMember cxac:SponsorMember 2022-03-31 0001856242 cxac:SponsorMember cxac:WorkingCapitalLoansMember 2022-03-31 0001856242 cxac:SponsorMember cxac:PrivatePlacementWarrantMember 2022-03-31 0001856242 us-gaap:CommonClassAMember cxac:PrivatePlacementWarrantMember 2022-03-31 0001856242 us-gaap:PrivatePlacementMember cxac:PrivatePlacementWarrantMember 2022-03-31 0001856242 us-gaap:IPOMember 2022-03-31 0001856242 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-03-31 0001856242 cxac:PublicWarrantsMember 2022-03-31 0001856242 cxac:UnderwritingAgreementMember 2022-03-31 0001856242 us-gaap:CommonClassBMember 2021-12-31 0001856242 us-gaap:CommonClassAMember 2021-12-31 0001856242 cxac:WorkingCapitalLoansMember 2021-12-31 0001856242 cxac:SponsorMember cxac:PromissoryNoteMember 2021-12-31 0001856242 us-gaap:AccountsPayableAndAccruedLiabilitiesMember cxac:SponsorMember 2021-12-31 0001856242 us-gaap:CommonClassAMember 2022-01-11 0001856242 us-gaap:IPOMember 2022-01-11 0001856242 us-gaap:IPOMember us-gaap:CommonClassAMember 2022-01-11 0001856242 us-gaap:PrivatePlacementMember 2022-01-11 0001856242 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-11 0001856242 cxac:SponsorMember cxac:FounderSharesMember 2021-05-18 0001856242 cxac:FounderSharesMember cxac:SponsorMember us-gaap:CommonClassBMember 2021-05-18 2021-05-18 0001856242 us-gaap:OverAllotmentOptionMember cxac:FounderSharesMember cxac:SponsorMember 2021-05-18 2021-05-18 0001856242 cxac:PromissoryNoteMember cxac:SponsorMember 2021-05-20 0001856242 cxac:PromissoryNoteMember cxac:SponsorMember 2021-06-04 2021-06-04 0001856242 us-gaap:OverAllotmentOptionMember 2022-01-11 2022-01-11 0001856242 us-gaap:IPOMember 2022-01-11 2022-01-11 0001856242 us-gaap:PrivatePlacementMember 2022-01-11 2022-01-11 0001856242 cxac:PublicWarrantsMember 2022-01-11 2022-01-11 0001856242 cxac:PrivatePlacementWarrantsMember 2022-01-11 2022-01-11 0001856242 us-gaap:CommonClassAMember 2022-05-16 0001856242 us-gaap:CommonClassBMember 2022-05-16 0001856242 cxac:FounderSharesMember us-gaap:OverAllotmentOptionMember 2022-01-06 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001856242 us-gaap:RetainedEarningsMember 2021-12-31 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001856242 us-gaap:RetainedEarningsMember 2022-03-31 0001856242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-29 0001856242 us-gaap:AdditionalPaidInCapitalMember 2021-03-29 0001856242 us-gaap:RetainedEarningsMember 2021-03-29 0001856242 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001856242 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001856242 us-gaap:RetainedEarningsMember 2021-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Month utr:Year iso4217:USD xbrli:shares
Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(MARK ONE)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2022
or
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
Commission File Number:
001-40748
 
 
C5 Acquisition Corporation
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
  
86-3097106
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
1701 Pennsylvania Ave NW, Ste #460
Washington, D.C. 20006
(Address of principal executive offices, including zip code)
(202)
452-9133
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Units, each consisting of one share of share of Class A common stock and
one-half
of one redeemable public warrant
  
CXAC.U
  
New York Stock Exchange
Class A Common Stock, $0.0001 par value
  
CXAC
  
New York Stock Exchange
Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
  
CXAC WS
  
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “
Exchange Act
”), during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated
filer		   ☒    Smaller reporting company   ☒
 
 
 
 
 
 
 
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of May 16, 2022 there
were 28,750,000 shares of Class A common stock, $0.0001 par value, and 7,187,500 shares of Class B common stock, $0.0001 par value, issued and outstanding.
 
 
 
Table of Contents
C5 ACQUISITION CORPORATION
FORM
10-Q
FOR THE QUARTER ENDED MARCH 31, 2022
TABLE OF CONTENTS
 
 
  
Page
 
  
 
1
 
  
 
1
 
  
 
1
 
  
 
2
 
  
 
3
 
  
 
4
 
  
 
5
 
  
 
17
 
  
 
20
 
  
 
20
 
  
 
22
 
  
 
22
 
  
 
22
 
  
 
22
 
  
 
22
 
  
 
22
 
  
 
22
 
  
 
23
 
  
 
24
 
 
 
i
Table of Contents
PART I - FINANCIAL INFORMATION
Item 1. Interim Financial Statements.
C5 ACQUISITION CORPORATION
CONDENSED BALANCE SHEETS
 
 
  
March 31, 2022
 
 
December 31, 2021
 
 
  
(unaudited)
 
 
 
 
ASSETS
  
      
 
      
Current Assets:
  
      
 
      
Cash
    $ 1,646,117     $ 210,351  
Prepaid expenses
      616,482       —    
Other current assets
      65,363       —    
    
 
 
    
 
 
  
Total Current Assets
      2,327,962       210,351  
Other assets
      457,260       —    
Deferred offering costs
      —         476,457  
Investments held in the Trust Account
      293,296,766       —    
    
 
 
    
 
 
  
Total Assets
    $ 296,081,988     $ 686,808  
    
 
 
    
 
 
  
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND
STOCKHOLDER’S (DEFICIT) EQUITY
                 
Current Liabilities:
                 
Accounts payable and accrued expenses
    $ 303,745     $ 17,747  
Accrued offering costs
      395       365,845  
Note payable - Sponsor
      —         300,000  
Total Current Liabilities
      304,140       683,592  
    
 
 
    
 
 
  
Deferred underwriting commission
      10,062,500       —    
    
 
 
    
 
 
  
Total Liabilities
      10,366,640       683,592  
COMMITMENTS AND CONTINGENCIES (Note 6)
             
Class A common stock subject to possible redemption; 28,750,000 and no shares outstanding as of
March 31, 2022 and December 31, 2021, respectively (at $10.20 per share)
      293,250,000       —    
Stockholder’s (Deficit) Equity:
                 
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
        —       —    
Class A common stock, $0.0001 par value, 500,000,000 shares authorized, no shares issued and
outstanding at March 31, 2022 and December 31, 2021 (excluding 28,750,000 shares subject to
possible redemption)
        —       —    
Class B common stock, $0.0001 par value, 100,000,000 shares authorized, 7,187,500 shares issued and
outstanding at March 31, 2022 and December 31, 2021
      719       719  
Additional
paid-in
capital
      —         24,281  
Accumulated deficit
      (7,582,137 )      (21,784 ) 
    
 
 
    
 
 
  
Total Stockholder’s (Deficit) Equity
      (7,581,418 )      3,216  
    
 
 
    
 
 
  
Total Liabilities, Common Stock subject to Possible Redemption and Stockholder’s (Deficit) Equity
    $ 296,081,988     $ 686,808  
    
 
 
    
 
 
  
The accompanying notes are an integral part of the condensed financial statements.
Table of Contents
C5 ACQUISITION CORPORATION
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
    
For the Three
Months
Ended
March 31,

2022
    
For the Period
From March
30, 2021
(inception)
Through
March 31, 2021
  
EXPENSES
                 
Administrative fee - related party
    $ 92,581     $ —    
General and administrative
      409,292       90  
    
 
 
    
 
 
  
TOTAL EXPENSES
      501,873       90  
    
 
 
    
 
 
  
OTHER INCOME
                 
Income earned on investments held in Trust Account
      46,766       —    
    
 
 
    
 
 
  
TOTAL OTHER INCOME
      46,766       —    
    
 
 
    
 
 
  
LOSS BEFORE INCOME TAX PROVISION
      (455,107 )      (90 ) 
    
 
 
    
 
 
  
Income tax provision
      —          —    
    
 
 
    
 
 
  
Net loss
    $ (455,107 )    $ (90 ) 
    
 
 
    
 
 
  
Basic and diluted weighted average shares outstanding, Class A Common Stock
      25,236,111       —    
    
 
 
    
 
 
  
Basic and diluted net loss per share of Class A Common Stock
    $ (0.02 )    $ —    
    
 
 
    
 
 
  
Weighted average number of shares of Class B Common Stock outstanding, basic and diluted
      7,072,917       —    
    
 
 
    
 
 
  
Basic and diluted net loss per share of Class B Common Stock
    $ (0.02 )    $ —    
    
 
 
    
 
 
  
The accompanying notes are an integral part of the condensed financial statements.
 
2
Table of Contents
C5 ACQUISITION CORPORATION
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDER’S (DEFICIT) EQUITY
(UNAUDITED)
FOR THE THREE MONTHS ENDED MARCH 31, 2022
 
 
  
Class B Common Stock
 
  
Additional
Paid-in
Capital
 
 
Accumulated
Deficit
 
 
Total
Stockholder’s
Equity (Deficit)
 
 
  
Shares
 
  
Amount
 
Balance, January 1, 2022
      7,178,500      $ 719      $ 24,281     $ (21,784 )    $ 3,216  
Proceeds Allocated to Public Warrants
      —          —          11,514,821       —         11,514,821  
Proceeds from Private Warrants, net of offering costs
      —          —          15,007,880       —         15,007,880  
Value of transaction costs allocated to the fair value of equity instruments
      —          —          (654,468 )      —         (654,468 ) 
Remeasurement adjustment of Class A common stock to redemption value
      —          —          (25,892,514 )      (7,058,480 )      (32,950,994 )
Accretion of Class A common stock to redemption amount
                                (46,766 )      (46,766 ) 
Net loss
      —          —          —         (455,107 )      (455,107 ) 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance, March 31, 2022
      7,178,500      $ 719      $ —       $ (7,582,137 )    $ (7,581,418 ) 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
FOR THE PERIOD MARCH 30, 2021 (INCEPTION) THROUGH MARCH 31, 2021
 
    
Class B Common Stock
     
Additional
Paid-in

Capital
     
Accumulated
Deficit
    
Total
Stockholder’s
Equity
(Deficit)
  
    
     Shares     
     
Amount
  
Balance, March 30, 2021
      —        $ —        $ —          (90 )      (90 ) 
Net loss
      —          —          —          (90 )      (90 ) 
    
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance, March 31, 2021
      —        $ —        $ —        $ (90 )    $ (90 ) 
    
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
The accompanying notes are an integral part of the condensed financial statements.
 
3
Table of Contents
C5 ACQUISITION CORPORATION
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)

 
 
  
For the Three
Months Ended
March 31,

2022
 
 
For the Period
From March
30, 2021
(inception)
Through
March 31, 2021
 
Cash Flows From Operating Activities:
  
      
 
      
Net loss
    $ (455,107 )    $ (90 ) 
Adjustments to reconcile net loss to net cash used in operating activities:
                 
Investment income earned on
treasury
securities held in Trust Account
      (46,766 )      —    
Changes in operating assets and liabilities:
                 
Prepaid expenses
      (616,482 )      —    
Other current assets
      (65,363 )      —    
Other assets
      (457,260 )         
Accounts payable and accrued expenses
      285,998       90  
    
 
 
    
 
 
  
Net Cash Used In Operating Activities
      (1,354,980 )      —    
    
 
 
    
 
 
  
Cash Flows From Investing Activities:
                 
Cash deposited into Trust Account
      (293,250,000 )      —    
    
 
 
    
 
 
  
Net Cash Used In Investing Activities
      (293,250,000 )      —    
    
 
 
    
 
 
  
Cash Flows From Financing Activities:
                 
Sale of Units in the Initial Public Offering, net of underwriting discount
      281,750,000       —    
Sale of Private Placement Warrants to the Sponsor
      15,035,500       —    
Repayment of the Sponsor promissory note
      (300,000 )      —    
Payment of offering costs
      (444,754 )      —    
    
 
 
    
 
 
  
Net Cash Provided By Financing Activities
      296,040,746       —    
    
 
 
    
 
 
  
Net change in cash
      1,435,766       —    
Cash at beginning of period
      210,351       —    
    
 
 
    
 
 
  
Cash at end of period
    $ 1,646,117     $ —    
    
 
 
    
 
 
  
Supplemental disclosure of
non-cash
financing activities:
                 
Deferred underwriters’ compensation charged to temporary equity in connection with the Public Offering
    $
10,062,500
     $ —    
Class A Common Stock measurement adjustment
    $
32,950,994
     $ —    
Accretion of Class A common stock to redemption amount
    $ 46,766     $ —    
Offering costs included in accrued offering costs
    $
395
     $ —    
The accompanying notes are an integral part of the condensed financial statements.
 
4
Table of Contents
C5 ACQUISITION CORPORATION
NOTES TO THE FINANCIAL STATEMENTS
NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
C5 Acquisition Corporation (the “Company”) was incorporated in Delaware on March 30, 2021. The Company was formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
All activity for the period from March 30, 2021 (inception) through March 31, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”) as described below and search for a target company. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will
generate non-operating income
in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
On January 11, 2022, the Company consummated the Initial Public Offering of 28,750,000 units (“Units” and, with respect to the shares of common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $287,500,000, which is described in Note 3. This included an additional 3,750,000 Units purchased by the underwriters pursuant to the exercise of their option to purchase additional units (the “Over-Allotment Option”) in full.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) of an aggregate of 15,035,500 warrants (the “Private Placement Warrants”) to C5 Sponsor LLC (the “Sponsor”) at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $15,035,500
, which is described in Note 4.
Transaction costs related to the Initial Public Offering amounted to
$16,368,261 consisting of $5,750,000 of underwriting fees, $10,062,500 of deferred
underwriting fees payable (which are held in a trust account with Continental Stock Transfer & Trust Company acting as trustee (the “Trust Account”) and
$555,761 of other costs related to the Initial Public Offering.
Following the closing of the Initial Public Offering on January 11, 2022, an amount of $293,250,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in the Trust Account, which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of
Rule 2a-7 of
the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post- transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering, management has agreed that an amount equal to at least $10.20 per Unit sold in the Initial Public Offering, including proceeds of the Private Placement Warrants, will be held in the Trust Account.
 
5
Table of Contents
The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “
Distinguishing Liabilities from Equity
.”
All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in
ASC 480-10-S99, redemption
provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A common stock classified as temporary equity will be the allocated proceeds determined in accordance with
ASC 470-20. The
Class A common stock is subject to
ASC 480-10-S99. If
it is probable that the equity instrument will become redeemable, we have the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings,
additional paid-in capital).
The Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place. Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination.
The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to the Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the outstanding shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its second amended and restated certificate of incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
 
6
Table of Contents
Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.
The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to stockholders’ rights
or pre- business
combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
If the Company has not completed a Business Combination within 15 months from the closing of the Initial Public Offering (April 11, 2023) (the “Combination Period”), the Company will
 (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at
a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
The Sponsor has agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.20 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per public Share due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
 
7
Table of Contents
Going Concern, Liquidity and Management’s Plan
At March 31, 2022, the Company had cash of $1,646,117 and working capital of $2,023,822.
In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “
Disclosures of Uncertainties about an Entity
’
s Ability to Continue as a Going Concern
,” management has determined that the Company currently has less than 12 months from the date these financial statements were issued to complete a Business Combination within the Combination Period (initial completion without an extension ends on April 11, 2023), the mandatory liquidation requirement that the Company cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern. Management has determined that the Company has funds that are sufficient to fund the working capital needs of the Company until the consummation of an initial business combination or the winding up of the Company as stipulated in the Company’s amended and restated memorandum of association. While the Company believes it has sufficient access to additional sources of capital if necessary, there is no current commitment on the part of any financing source to provide additional capital and no assurances can be provided that such additional capital will ultimately be available. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. The accompanying financial statements have been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern. These unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Risks and Uncertainties
Management is currently evaluating the impact of
the COVID-19 pandemic
and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC.
Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed. As such, the information included in these financial statements should be read in conjunction with the audited financial statements as of December 31, 2021 filed with the SEC on Form
10-K
on March 29, 2022 and the Current Report on Form
8-K
filed with the SEC on January 19, 2022. In the opinion of the Company’s management, these condensed financial statements include all adjustments, which are only of a normal and recurring nature, necessary for a fair statement of the Company’s financial position as of March 31, 2022 and the Company’s results of operations and cash flows for the periods presented. The results of operations for the three months ended March 31, 2022 not necessarily indicative of the results to be expected for the full year ending December 31, 2022.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
8
Table of Contents
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth
companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the condensed financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.
Offering Costs associated with Initial Public Offering
The Company complies with the requirements of the Financial Accounting Standards Board ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“
SAB
”) Topic 5A, “
Expenses of Offering
.” Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Units were allocated between temporary equity and the Public Warrants by the relative fair value method. Offering costs of $555,761 consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $15,812,500, were allocated between temporary equity, the Public Warrants and the Private Warrants in a relative fair value method upon completion of the Initial Public Offering.
Class A common stock subject to possible redemption
The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity”. Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholder’s equity. The shares of the Company’s Class A common stock feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at
March
 
3
1, 2022, the shares of Class A common stock subject to possible redemption in the amount of $293,250,000 are presented as temporary equity, outside of the stockholder’s deficit section of the Company’s balance sheet.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of Class A Common Stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized a measurement adjustment from initial book value to redemption amount value. The change in the carrying value of redeemable shares of Class A Common Stock resulted in charges against additional
paid-in
capital and accumulated deficit.
 
9
Table of Contents
At March 31, 2022, the Class A common stock reflected in the balance sheet is reconciled in the following table:
 
Gross proceeds
    $ 287,500,000  
Less:
   
Proceeds allocated to Public Warrants
      (11,514,821 ) 
Class A common stock issuance costs
      (15,686,173 ) 
  
 
 
  
    
(27,200,994)
  
Plus:
   
Remeasurement adjustment to redemption value
      32,950,994  
Current period adjustment to redemption value
      46,766  
  
 
 
  
Class A common stock subject to possible redemptio
n
    $ 293,296,766  
  
 
 
  
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC 740, “
Income Taxes
.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
The Company’s deferred tax assets were deemed to be de minimis as of March 31, 2022 and December 31, 2021.
Net Loss per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “
Earnings Per Share.
” Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period. The Company applies the
two-class
method in calculating earnings per share. The remeasurement adjustment associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted loss per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement. As a result, diluted earnings per share of common stock is the same as basic earnings per common stock for the periods presented. As of March 31, 2022, the warrants are exercisable to purchase 16,000,000 shares of Class A common stock in the aggregate. As of March 31, 2021, there were no shares or warrants outstanding.
 
10
Table of Contents
The following table reflects the calculation of basic and diluted net loss per share of common stock.
 
    
Three months ended
March 31, 2022
  
Class A Common Stock
         
Numerator: Loss allocable to Class A Common Stock
    $ (392,006 ) 
Denominator: Basic and diluted weighted average shares outstanding
      25,236,111  
    
 
 
  
Basic and diluted net loss per share, Class A Common Stock
    $ (0.02 ) 
    
 
 
  
Class B Common Stock
         
Numerator: Loss allocable to Class B Common Stock
    $ (109,867 ) 
Denominator: Basic and diluted weighted average shares outstanding
      7,072,917  
    
 
 
  
Basic and diluted net loss per share, Class B Common Stock
    $ (0.02 ) 
    
 
 
  
Fair Value of Financial Instruments
Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
  •  
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
  •  
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
  •  
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
NOTE 3 — INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering on January 11, 2022, the Company sold 28,750,000 Units at a purchase price of $10.00 per Unit generating gross proceeds to the Company in the amount of $287,500,000. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Class A common
stock”), and one-half of one
redeemable public warrant of the Company (each whole public warrant, a “Public Warrant”), with each whole Public Warrant entitling the holder thereof to purchase one whole share of Class A Common Stock at a price of $11.50 per share, subject to adjustment.
 
11
Table of Contents
This included an additional 3,750,000 Units purchased by the underwriters pursuant to the exercise of their option to purchase additional units (the “Over-Allotment Option”) in full generating gross proceeds of $37,500,000.
NOTE 4 — PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of an aggregate of 15,035,500 Private Placement Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $15,035,500. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).
The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain exceptions.
NOTE 5 — RELATED PARTIES
Founder Shares
On May 18, 2021, the Sponsor received 7,187,500 of the Company’s Class B common stock (the “Founder Shares”) for $25,000. The Founder Shares include an aggregate of up to 937,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will equal, on an
as-converted
basis, approximately 20% of the Company’s issued and outstanding shares of common stock after the Initial Public Offering.
 
As a result of the underwriters’ election to partially exercise their overallotment option on January 6, 2022, no Founder Shares are currently subject to forfeiture (see Note 6).
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Promissory Note — Related Party
On May 20, 2021, the Sponsor issued an unsecured promissory note to the Company (as amended, the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note
is non-interest bearing
and payable on the earlier of (i) December 31, 2022 or (ii) the consummation of the Initial Public Offering. On June 4, 2021, the Company borrowed $300,000 under the Promissory Note.
On January 11, 2022, the amount outstanding under the Promissory Note was paid in full. As of March 31, 2022 and December 31, 2021,
$0 and $300,000 were outstanding under the Promissory Note, respectively.
General and Administrative Services
Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $35,000 per month for office space, utilities and secretarial and administrative support for up to 15 months, which includes up to approximately $22,000 per month payable to our Chief Financial Officer and consultants to assist us with our search for a target business. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. During the three months ended March 31, 2022, the Company recorded $92,581 under the service agreement. As of March 31, 2022 and December 31, 2021, the outstanding balance due to the Sponsor under the agreement was $35,000 and $0, respectively, and is in accounts payable and accrued expenses on the accompanying condensed balance sheets.
 
12
Table of Contents
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under the Working Capital Loans.
NOTE 6 — COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their
lock-up
restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a
45-day
option from the date of Initial Public Offering to purchase up to 3,750,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On January 11, 2022, the underwriters fully exercised their option to purchase additional units. The exercise of the option generated gross proceeds of $37,500,000 to the Company.
The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $5,750,000, upon the closing of the Initial Public Offering. In addition, the underwriters will be entitled to a deferred fee of $0.35 per Unit, or $10,062,500. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Financial Advisor Engagement
Following the completion of the Company’s Initial Public Offering, the Company entered into an engagement letter (the “Engagement Letter”) with a financial advisor in connection with an initial business combination and as a placement agent in connection with related private placement transactions (each, a “PIPE transaction”). In connection with the Engagement Letter and upon closing of the initial business combination and PIPE transaction, the Company has agreed pay the advisor a transaction fee based on the value of the initial business combination and a transaction fee with respect to each completed PIPE transaction, in each case, pursuant to the terms of the Engagement Letter. The advisor also participated in the Company’s Initial Public Offering as an underwriter.
 
13
Table of Contents
NOTE 7 — STOCKHOLDER’S (DEFICIT) EQUITY
Preferred Stock
 — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.
Class
 A Common Stock
 — The Company is authorized to issue 500,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of March 31, 2022, there were 28,750,000 shares of the Class A Common Stock that were classified as temporary equity in the accompanying balance sheet. As of December 31, 2021, there were no shares of Class A common stock issued or outstanding.
Class
 B Common Stock
 — The Company is authorized to issue 100,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 7,187,500 shares of Class B common stock issued and outstanding.
Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders, including the election of directors, except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.
The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a
one-for-one
basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.
Warrants
 —Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.
 
14
Table of Contents
The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemption of Public Warrants — Once the Public Warrants become exercisable, the Company may redeem the outstanding public warrants:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per Public Warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption, or
the 30-day redemption
period to each Public Warrant holder; and
 
  •  
if, and only if, the last reported sale price of the Class A common stock has been at least $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 10 trading days within
a 20-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to Public Warrant holders.
The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout
the 30-day redemption
period or the Company elected to require the exercise of the Public Warrants on a “cashless basis” as described below. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will
be non-redeemable and
will be exercisable at the election of the holder on a “cashless basis”. The warrant agreements contain a provision wherein warrant holders can receive an “alternative issuance”, including as a result of a tender offer that constitutes a change of control.
 
15
Table of Contents
The Company accounts for the 29,410,500 warrants to be issued in connection with the Initial Public Offering (including 14,375,000 Public Warrants and 15,035,500 Private Placement Warrants) in accordance with the guidance contained
in ASC 815-40. Such
guidance provides that the warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.
NOTE 8 — SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in these financial statements.
 
16
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References to the “
Company
,” “
C5 Acquisition Corporation
,” “
our
,” “
us
” or “
we
” refer to C5 Acquisition Corporation, references to “
management
” or “
management team
” refer to the Company’s officers and directors and references to the “
Sponsor
” refer to C5 Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form
10-Q
(this “
Quarterly Report
”). Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report includes, and oral statements made from time to time by representatives of the Company may include, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act and are intended to be covered by the safe harbor created thereby. The Company has based these forward-looking statements on management’s current expectations, projections and forecasts about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about the Company that may cause its actual business, financial condition, results of operations, performance and/or achievements to be materially different from any future business, financial condition, results of operations, performance and/or achievements expressed or implied by these forward-looking statements. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in the Company’s other filings with the SEC. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “target,” “goal,” “shall,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. In addition, any statements that refer to expectations, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.
Overview
We are a blank check company formed under the laws of the State of Delaware on March 30, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from March 30, 2021 (inception) through March 31, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and the search for a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We expect to
generate non-operating income
in the form of interest income on marketable securities held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, we had a net loss of $455,107, which consists of operating costs of $501,873 offset by interest earned on marketable securities held in the Trust Account of $46,766.
For the period from March 30, 2021 (inception) through March 31, 2021, we had a net loss of $90, which consists of formation and operating costs.
 
17
Table of Contents
Liquidity and Capital Resources
On January 11, 2022, we consummated the Initial Public Offering of 28,750,000 Units at a price of $10.00 per Unit, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units, generating gross proceeds of $287,500,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 15,035,500 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to our Sponsor, generating gross proceeds of $15,035,500.
Following the Initial Public Offering, the full exercise of the over-allotment option by the underwriters’ and the sale of the Private Placement Warrants, a total of $293,250,000 was placed in the Trust Account and as of March 31, 2022, we had $1,646,117 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. Transaction costs amounted to $16,368,261 consisting of $5,750,000 of underwriting fees, $10,062,500 of deferred underwriting fees payable and $555,761 of other offering costs.
For the three months ended March 31, 2022, cash used in operating activities was $1,354,980 which consisted of the net loss of $455,107, interest earned on marketable securities held in the Trust Account of $46,766 and changes in operating liabilities used $853,107 of cash from operating activities.
As of March 31, 2022, we had marketable securities held in the Trust Account of $293,296,766, including $46,766 of interest income, consisting of mutual funds invested primarily in U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our Business Combination. We may withdraw interest to pay franchise and income taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of March 31, 2022, we had cash of $1,646,117. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. The loans would be repaid upon consummation of a Business Combination, without interest.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business,
undertaking in-depth due
diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
 
18
Table of Contents
Off-Balance
Sheet Financing Arrangements
We have no obligations, assets or liabilities, which would be
considered off-balance sheet
arrangements as of March 31, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of
facilitating off-balance sheet
arrangements. We have not entered into
any off-balance sheet
financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased
any non-financial assets.
Contractual Obligations
As of March 31, 2022, we do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.
Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $35,000 per month for office space, utilities and secretarial and administrative support for up to 15 months, which includes up to approximately $22,000 per month payable to our Chief Financial Officer and consultants to assist us with our search for a target business. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.
The underwriters will be entitled to a deferred fee of $0.35 per Unit, or $10,062,500 in the aggregate. The deferred fee will be waived by the underwriters in the event that we do not complete a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Offering Costs associated with Initial Public Offering
The Company complies with the requirements of the Financial Accounting Standards Board ASC
340-10-S99-1
and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, “Expenses of Offering.” Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Units were allocated between temporary equity and the Public Warrants by the relative fair value method. Offering costs of $555,761 consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $15,812,500, were allocated between temporary equity, the Public Warrants and the Private Warrants in a relative fair value method upon completion of the Initial Public Offering.
Class A Common Stock Subject to Possible Redemption
We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “
Distinguishing Liabilities from Equity
.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholder’s equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholder’s (deficit) equity section of our balance sheet.
 
19
Table of Contents
Net Loss per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “
Earnings Per Share
.” Net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period. The Company applies the two-class method in calculating earnings per share. The remeasurement adjustment associated with the redeemable shares of Class A Common Stock is excluded from earnings per share as the redemption value approximates fair value.
The calculation of diluted loss per share of common stock does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement. As a result, diluted earnings per share of common stock is the same as basic earnings per common stock for the periods presented. As of March 31, 2022, the warrants are exercisable to purchase 16,000,000 shares of Class A common stock in the aggregate. As of March 31, 2021, there were no shares or warrants outstanding.
Fair Value of Financial Instruments
Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Following the consummation of our initial public offering (the “Initial Public Offering”), the net proceeds of our Initial Public Offering, including amounts in the trust account (the “Trust Account”), have been invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk. As of March 31, 2022, we were not subject to any market or interest rate risk.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current Chief Executive Officer and Chief Financial Officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of March 31, 2022, pursuant to
Rule 13a-15(b) under
the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of March 31, 2022, our disclosure controls and procedures were effective.
 
20
Table of Contents
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Management’s Report on Internal Controls Over Financial Reporting
This Quarterly Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public companies or emerging growth companies.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in
Rules 13a-15(f) and 15d-15(f) of
the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
21
Table of Contents
PART
II-OTHER
INFORMATION
Item 1. Legal Proceedings.
None.
Item 1A. Risk Factors.
Factors that could cause the Company’s actual business, financial condition and/or results of operations to differ materially from those in this Quarterly Report are any of the risks factors described in our annual report on Form
10-K
for the fiscal year ended December 31, 2021, filed with the Securities Exchange Commission (the “SEC”) on March 29, 2022. Any of these risk factors could result in a significant or material adverse effect on the Company’s business, financial condition and/or results of operations. Additional risk factors not presently known to the Company or that the Company currently deems immaterial may also impair the Company’s business, financial condition and/or results of operations.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On January 11, 2022, we completed our Initial Public Offering of 28,750,000 units at a price of $10.00 per unit, generating gross proceeds of $287,500,000. Each unit consists of one of the Company’s shares of Class A common stock, par value $0.0001 per share,
and one-half of
one warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments. Following the closing of the Initial Public Offering, an aggregate of $293,250,000 was placed in the trust account.
Concurrently with the completion of the Initial Public Offering, our sponsor purchased an aggregate of 15,035,500 warrants at a price of $1.00 per warrant, or $15,035,500 in the aggregate. An aggregate of $293,250,000 was placed in a trust account at the time of closing of the Initial Public Offering. Each whole private placement warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to certain adjustments.
On January 11, 2022, the underwriters fully exercised their option to purchase additional units. The exercise of the option generated gross proceeds of $37,500,000 to the Company.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
 
22
Table of Contents
Item 6. Exhibits
 
No.
   
Description of Exhibit
   
  3.1    Amended and Restated Certificate of Incorporation. (1)
   
  4.1    Public Warrant Agreement, dated January 6, 2022 between the Company and Continental Stock Transfer & Trust Company, as warrant agent.(1)
   
  4.2    Private Warrant Agreement, dated January 6, 2022 between the Company and Continental Stock Transfer & Trust Company, as warrant agent. (1)
   
10.1    Letter Agreement, dated January 6, 2022, among the Company, Guggenheim, the Company’s officers and directors and the Sponsor(1)
   
10.2    Investment Management Trust Agreement, dated January 6, 2022, between the Company and Continental Stock Transfer & Trust Company, as trustee. (1)
   
10.3    Registration Rights Agreement, dated January 6, 2022, among the Company and certain security holders. (1)
   
10.4    Private Placement Warrants Purchase Agreement, dated January 6, 2022, between the Company and the Sponsor. (1)
   
10.5    Indemnity Agreement, dated January 6, 2022, between the Company and Steven J. Demetriou. (1)
   
10.6    Indemnity Agreement, dated January 6, 2021, between the Company and David Glickman. (1)
   
10.7    Indemnity Agreement, dated January 6, 2022, between the Company and Arun Gupta. (1)
   
10.8    Indemnity Agreement, dated January 6, 2022, between the Company and Robert Meyerson. (1)
   
10.9    Indemnity Agreement, dated January 6, 2022, between the Company and Jeanne Tisinger. (1)
   
10.10    Indemnity Agreement, dated January 6, 2022, between the Company and Linda Zecher. (1)
   
10.11    Administrative Services Agreement, dated May 27, 2021, between the Company and the Sponsor. (1)
   
31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS*   
Inline XBRL Instance Document-this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
   
101.SCH*   
Inline XBRL Taxonomy Extension Schema Document
   
101.CAL*   
Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF*   
Inline
XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB*   
Inline
 
XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE*   
Inline
 
XBRL Taxonomy Extension Presentation Linkbase Document
   
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
(1)
Previously filed as an exhibit to our Current Report on Form
8-K
filed on January 12, 2022 and incorporated by reference herein.
*
Filed herewith.
**
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended, and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.
 
23
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 16, 2022
 
C5 ACQUISITION CORPORATION
   
By:  
/s/ Robert Meyerson
    Robert Meyerson
    Chief Executive Officer and Director (Principal Executive Officer)
   
By:  
/s/ David Glickman
    David Glickman
    Chief Business Development Officer and Chief Financial Officer (Principal Financial and Accounting Officer)
 
24